Skip to main content
SpringerLink
Log in

Carbamazepine

  • Chapter
  • First Online:
Antiepileptic Drug Interactions

  • 1465 Accesses

Abstract

Salicylic acid does not affect the pharmacokinetics of carbamazepine [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Neuvonen PJ, Lehtovaara R, Bardy A, Elomaa E. Antipyretic analgesics in patients on antiepileptic drug therapy. Eur J Clin Pharmacol. 1979;15:263–8.

    Article  PubMed  CAS  Google Scholar 

  2. Hansen SB, Dam M, Brandt J, Hvidberg EF, Angelo H, Christensen JM, Lous P. Influence of dextropropoxyphene on steady state serum levels and protein binding of three anti-epileptic drugs in man. Acta Neurol Scand. 1980;61:357–67.

    Article  PubMed  CAS  Google Scholar 

  3. Bergendal L, Friberg A, Schaffrath AM, Holmdahl M, Landahl S. The clinical relevance of the interaction between carbamazepine and dextropropoxyphene in elderly patients in Gothenburg, Sweden. Eur J Clin Pharmacol. 1997;53:203–6.

    Article  PubMed  CAS  Google Scholar 

  4. Yu YL, Huang CY, Chin D, Woo E, Chang CM. Interaction between carbamazepine and dextropropoxyphene. Postgrad Med J. 1986;62:231–3.

    Article  PubMed  CAS  Google Scholar 

  5. Garey KW, Amsden GW. Intravenous azithromycin. Ann Pharmacother. 1999;33:218–28.

    Article  PubMed  CAS  Google Scholar 

  6. Shahzadi A, Javed I, Aslam B, Muhammad F, Asi MR, Ashraf MY, Zia-ur-Rahman. Therapeutic effects of ciprofloxacin on the pharmacokinetics of carbamazepine in healthy adult male volunteers. Pak J Pharm Sci. 2011;24:63–8.

    Google Scholar 

  7. Albani F, Riva R, Baruzzi A. Clarithromycin-carbamazepine interaction: a case report. Epilepsia. 1993;34:161–2.

    Article  PubMed  CAS  Google Scholar 

  8. Yasui N, Otani K, Kaneko S, Shimoyama R, Ohkubo T, Sugawara K. Carbamazepine toxicity induced by clarithromycin coadministration in psychiatric patients. Int Clin Psychopharmacol. 1997;12:225–9.

    Article  PubMed  CAS  Google Scholar 

  9. Watkins VS, Polk RE, Stotka JL. Drug interactions of macrolides: emphasis on dirithromycin. Ann Pharmacother. 1997;31:349–56.

    PubMed  CAS  Google Scholar 

  10. Barzaghi N, Gatti G, Crema F, Monteleone M, Amione C, Leone L, Perucca E. Inhibition by erythromycin of the conversion of carbamazepine to its active 10,11-epoxide metabolite. Br J Clin Pharmacol. 1987;24:836–8.

    Article  PubMed  CAS  Google Scholar 

  11. Barzaghi N, Gatti G, Crema F, Faja A, Monteleone M, Amione C, Leone L, Perucca E. Effect of flurithromycin, a new macrolide antibiotic, on carbamazepine disposition in normal subjects. Int J Clin Pharmacol Res. 1988;8:101–5.

    PubMed  CAS  Google Scholar 

  12. Marsden JR. Effect of isotretinoin on carbamazepine pharmacokinetics. Br J Dermatol. 1988;119:403–4.

    Article  PubMed  CAS  Google Scholar 

  13. Vincon G, Albin H, Demotes-Mainard F, Guyot M, Bistue C, Loiseau P. Effects of josamycin on carbamazepine kinetics. Eur J Clin Pharmacol. 1987;32:321–3.

    Article  PubMed  CAS  Google Scholar 

  14. Patterson BD. Possible interaction between metronidazole and carbamazepine. Ann Pharmacother. 1994;28:1303–4.

    PubMed  CAS  Google Scholar 

  15. Couet W, Istin B, Ingrand I, Girault J, Fourtillan JB. Effect of ponsinomycin on single-dose kinetics and metabolism of carbamazepine. Ther Drug Monit. 1990;12:144–9.

    Article  PubMed  CAS  Google Scholar 

  16. Saint-Salvi B, Tremblay D, Surjus A, Lefebve MA. A study of the interaction of roxithromycin with theophylline and carbamazepine. J Antimicrob Chemother. 1987;20 (Suppl B):121–9.

    Article  PubMed  CAS  Google Scholar 

  17. Mesdjian E, Dravet C, Cenraud B, Roger J. Carbamazepine intoxication due to triacetyloleandomycin administration in epileptic patients. Epilepsia. 1980;21:489–96.

    Article  PubMed  CAS  Google Scholar 

  18. Ulivelli M, Rubegni P, Nuti D, Bartalini S, Giannini S, Rossi S. Clinical evidence of fluconazole-induced carbamazepine toxicity. J Neurol. 2004;251:622–3.

    Article  PubMed  Google Scholar 

  19. Spina E, Arena S, Scordo MG, Fazio A, Pisan F, Perucca E. Elevation of plasma carbamazepine concentrations by ketoconazole in patients with epilepsy. Ther Drug Monit. 1997;19:535–8.

    Article  PubMed  CAS  Google Scholar 

  20. Loupi E, Descotes J, Lery N, Evreux JC. Interactions medicamenteuses et miconazole. A propos de 10 observations. Therapie. 1982;37:437–41.

    PubMed  CAS  Google Scholar 

  21. Neef C, de Voogd-van der Straaten I. An interaction between ­cytostatic and anticonvulsant drugs. Clin Pharmacol Ther. 1988;43:372–5.

    Article  PubMed  CAS  Google Scholar 

  22. Rabinowicz AL, Hinton DR, Dyck P, Couldwell WT. High-dose tamoxifen in treatment of brain tumors: interaction with antiepileptic drugs. Epilepsia. 1995;36:513–5.

    Article  PubMed  CAS  Google Scholar 

  23. Valsalan VC, Cooper GL. Carbamazepine intoxication caused by interaction with isoniazid. Br Med J. 1982;285:261–2.

    Article  CAS  Google Scholar 

  24. Block SH. Carbamazepine-isoniazid interaction. Pediatrics. 1982;69:494–5.

    PubMed  CAS  Google Scholar 

  25. Desai J. Perspectives on interactions between antiepileptic drugs (AEDs) and antimicrobials. Epilepsia. 2008;49 (Suppl) 6:47–9.

    Article  PubMed  Google Scholar 

  26. Sonne J, Luhdorf K, Larsen NE, Andreasen PB. Lack of interaction between cimetidine and carbamazepine. Acta Neurol Scand. 1983;68:253–6.

    Article  PubMed  CAS  Google Scholar 

  27. Dalton MJ, Powell R, Messenheimer JA, Clark J. Cimetidine and carbamazepine: a complex drug interaction. Epilepsia. 1986;27(5):553–8.

    Article  PubMed  CAS  Google Scholar 

  28. Webster LK, Mihaly GW, Jones DB, Smallwood RA, Philips JA, Vajda FJ. Effect of cimetidine and ranitidine on carbamazepine and sodium valproate pharmacokinetics. Eur J Clin Pharmacol. 1984;27:341–3.

    Article  PubMed  CAS  Google Scholar 

  29. Bottiger Y, Bertilsson L. No effect on plasma carbamazepine concentration with concomitant omeprazole. Drug Investig. 1995;9:180–1.

    Article  Google Scholar 

  30. Naidu MUR, Shoba J, Dixit VK, Kumar TR, Sekhar EC. Effect of multiple dose omeprazole on the pharmacokinetics of carbamazepine. Drug Investig. 1994;7:8–12.

    Article  Google Scholar 

  31. Huber R, Bliesath H, Hartmann M, Steinijans VW, Koch H, Mascher H, Wurst W. Pantoprazole does not interact with the pharmacokinetics of carbamazepine. Int J Clin Pharmacol Ther. 1998;36:521–4.

    PubMed  CAS  Google Scholar 

  32. Ji P, Damle B, Xie J, Unger SE, Grasela DM, Kaul S. Pharmacokinetic interaction between efavirenz and carbamazepine after multiple-dose administration in healthy subjects. J Clin Pharmacol. 2008;48:948–56.

    Article  PubMed  CAS  Google Scholar 

  33. Bates DE, Herman RJ. Carbamazepine toxicity induced by lopinavir/ritonavir and nelfinavir. Ann Pharmacother. 2006;40:1190–5.

    Article  PubMed  Google Scholar 

  34. Garcia AB, Ibarra AL, Etessam JP, Salio AM, Martinez DAP, Diaz RS, Hera MT. Protease inhibitor-induced carbamazepine toxicity. Clin Neuropharmacol. 2000;23:216–8.

    Article  Google Scholar 

  35. Leite SAO, Leite PJM, Rocha GA, Routledge PA, Bittencourt PRM. Carbamazepine kinetics in cardiac patients before and during amiodarone. Arq Neuropsiquiatr. 1994;52:210–5.

    Article  PubMed  CAS  Google Scholar 

  36. Shaughnessy AF, Mosley MR. Elevated carbamazepine levels associated with diltiazem use. Neurology. 1992;42:937–8.

    Article  PubMed  CAS  Google Scholar 

  37. Brodie MJ, Macphee GJA. Carbamazepine neurotoxicity precipitated by diltiazem. Br Med J. 1986;292:1170–1.

    Article  CAS  Google Scholar 

  38. Macphee GA, McInnes GT, Thompson GG, Brodie MJ. Verapamil potentiates carbamazepine neurotoxicity: a clinically important inhibitory interaction. Lancet. 1986;1:700–3.

    Article  PubMed  CAS  Google Scholar 

  39. Brown RIG, Cooper TG. Ticlopidine-carbamazepine interaction in a coronary stent patient. Can J Cardiol. 1997;13:853–4.

    PubMed  CAS  Google Scholar 

  40. Neuvonen PJ, Kivisto K, Hirvisalo EL. Effects of resins and activated charcoal on the absorption of digoxin, carbamazepine and frusemide. Br J Clin Pharmacol. 1988;25:229–33.

    Article  PubMed  CAS  Google Scholar 

  41. Denio L, Drake ME, Pakalnis A. Gemfibrozil-carbamazepine interaction in epileptic patients. Epilepsia. 1988;29:654.

    Google Scholar 

  42. Poondru S, Devaraj R, Boinpally RR, Yamsani MR. Time-dependent influence of pentoxifylline on the pharmacokinetics of orally administered carbamazepine in human subjects. Pharmacol Res. 2001;43:301–5.

    Article  PubMed  CAS  Google Scholar 

  43. Garg SK, Kumar N, Bhargava VK, Prabhakar SK. Effect of grapefruit juice on carbamazepine bioavailability in patients with epilepsy. Clin Pharmacol Ther. 1998;64:286–8.

    Article  PubMed  CAS  Google Scholar 

  44. Burstein AH, Horton RL, Dunn T, Alfaro RM, Piscitelli SC, Theodore W. Lack of effect of St. John’s Wort on carbamazepine pharmacokinetics in healthy volunteers. Clin Pharmacol Ther. 2000;68:605–12.

    Article  PubMed  CAS  Google Scholar 

  45. Pitterle ME, Collins DM. Carbamazepine-10,11-epoxide evaluation associated with coadministration of loxitane and amoxapine. Epilepsia. 1998;29:654.

    Google Scholar 

  46. Moller SE, Larsen F, Khant AZ, Rolan PE. Lack of effect of citalopram on the steady-state pharmacokinetics of carbamazepine in healthy male subjects. J Clin Psychopharmacol. 2001;21:493–9.

    Article  PubMed  CAS  Google Scholar 

  47. Grimsley SR, Jann MW, Carter JG, D’Mello AP, D’Souza MJ. Increased carbamazepine plasma concentrations after fluoxetine coadministration. Clin Pharmacol Ther. 1991;50:10–5.

    Article  PubMed  CAS  Google Scholar 

  48. Spina E, Avenoso A, Pollicino AM, Caputi AP, Fazio A, Pisani F. Carbamazepine coadministration with fluoxetine and fluvoxamine. Ther Drug Monit. 1993;15:247–50.

    Article  PubMed  CAS  Google Scholar 

  49. Fritze J, Unsorg B, Lanczik M. Interaction between carbamazepine and fluvoxamine. Acta Psychiatr Scand. 1991;84:583–4.

    Article  PubMed  CAS  Google Scholar 

  50. Ashton AK, Wolin RE. Nefazodone-induced carbamazepine toxicity. Am J Psychiatry. 2001;153:733.

    Google Scholar 

  51. Roth L, Bertschy G. Nefazodone may inhibit the metabolism of carbamazepine: three case reports. Eur Psychiatry. 2001;16:320–1.

    Article  PubMed  CAS  Google Scholar 

  52. Laroudie C, Salazar DE, Cosson JP, Cheuvart B, Istin B, Girault J, Ingrand I, Decourt JP. Carbamazepine-nefazodone interaction in healthy subjects. J Clin Psychopharmacol. 2000;20:46–53.

    Article  PubMed  CAS  Google Scholar 

  53. Andersen BB, Mikkelsen M, Vesterager A, Dam M, Kristensen HB, Pedersen B, Lund J, Mengel H. No influence of the antidepressant paroxetine on carbamazepine, valproate and phenytoin. Epilepsy Res. 1991;10:201–4.

    Article  PubMed  CAS  Google Scholar 

  54. Rapeport WG, Williams SA, Muirhead DC, Dewland PM, Tanner T, Wesnes K. Absence of a sertraline-mediated effect on the pharmacokinetics and pharmacodynamics of carbamazepine. J Clin Psychiatry. 1996;57 (Suppl) 1:20–3.

    PubMed  CAS  Google Scholar 

  55. Romero AS, Delgado RG, Pena MF. Interaction between trazodone and carbamazepine. Ann Pharmacother. 1999;33:1370.

    Article  PubMed  CAS  Google Scholar 

  56. Wiklander B, Danjou P, Rolan P, Tamin SK, Toon S. Evaluation of the potential pharmacokinetic interaction of venlafaxine and carbamazepine. Eur Neuropsychopharmacol. 1995;6:310–1.

    Article  Google Scholar 

  57. Pisani F, Fazio A, Oteri G, Perucca E, Russo M, Trio R, Pisani B, Di Perri R. Carbamazepine-viloxazine interaction in patients with epilepsy. J Neurol Neurosurg Psychiatry. 1986;49:1142–5.

    Article  PubMed  CAS  Google Scholar 

  58. Iwahashi K, Miyatake R, Suwaki H, Hosokawa K, Ichikawa Y. The drug-drug interaction effects of haloperidol on plasma carbamazepine levels. Clin Neuropharmacol. 1995;18:233–6.

    Article  PubMed  CAS  Google Scholar 

  59. Fitzgerald BJ, Okos AJ. Elevation of carbamazepine-10,11-epoxide by quetiapine. Pharmacotherapy. 2002;22:1500–3.

    Article  PubMed  Google Scholar 

  60. Mula M, Monaco F. Carbamazepine-risperidone interactions in patients with epilepsy. Clin Neuropharmacol. 2002;25:97–100.

    Article  PubMed  CAS  Google Scholar 

  61. Spina E, Amendola D’Agostino AM, Ioculano MP, Oteri G, Fazio A, Pisani F. No effect of thioridazine on plasma concentrations of carbamazepine and its active metabolite carbamazepine-10,11-epoxide. Ther Drug Monit. 1990;12:511–3.

    Article  PubMed  CAS  Google Scholar 

  62. Zielinski JJ, Lichten EM, Haidukewych D. Clinically significant danazol-carbamazepine interaction. Ther Drug Monit. 1987;9:24–7.

    Article  PubMed  CAS  Google Scholar 

  63. Krag B, Dam M, Angelo H, Christensen JM. Influence of disulfiram on the serum concentration of carbamazepine in patients with epilepsy. Acta Neurol Scand. 1981;63:395–8.

    Article  PubMed  CAS  Google Scholar 

  64. Robertson WC. Carbamazepine toxicity after influenza vaccination. Pediatr Neurol. 2003;26:61–3.

    Article  Google Scholar 

  65. Bourgeois BFD, Dodson WE, Ferrendelli JA. Interactions between primidone, carbamazepine, and nicotinamide. Neurology. 1982;32:1122–6.

    Article  PubMed  CAS  Google Scholar 

  66. Hilgar E, Quiner S, Ginzel I, Walter H, Saria L, Barnas C. The effect of orlistat on plasma levels of psychotropic drugs in patients with long-term psychopharmacology. J Clin Psychopharmacol. 2002;22:68–70.

    Article  Google Scholar 

  67. van Wieringen A, Meijer JWA, van Emde Boas W, Vermeij TAC. Pilot study to determine the interaction of oxiracetam with antiepileptics. Clin Pharmacokinet. 1990;18:332–8.

    Article  PubMed  Google Scholar 

  68. Kim KA, Oh SO, Park PW, Park JY. Effect of probenecid on the pharmacokinetics of carbamazepine in healthy subjects. Eur J Clin Pharmacol. 2005;61:275–80.

    Article  PubMed  CAS  Google Scholar 

  69. Hirschfeld S, Jarosinska P. Drug interaction of terfenadine and carbamazepine. Ann Intern Med. 1993;118:907–8.

    Article  PubMed  CAS  Google Scholar 

  70. Kulkarni C, Vaz J, David J, Joseph T. Aminophylline alters pharmacokinetics of carbamazepine but not that of sodium valproate – a single dose pharmacokinetic study in human volunteers. Indian J Physiol Pharmacol. 1995;39:122–6.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. UCL-Institute of Neurology Department of Clinical and Experimental Epilepsy, Queen Square, London, London

    P. N. Patsalos

  2. Epilepsy Society Chalfont Centre for Epilepsy, Chalfont St Peter, Buckinghamshire, UK

    P. N. Patsalos

Authors
  1. P. N. Patsalos
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag London

About this chapter

Cite this chapter

Patsalos, P.N. (2013). Carbamazepine. In: Antiepileptic Drug Interactions. Springer, London. https://doi.org/10.1007/978-1-4471-2434-4_29

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-2434-4_29

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-2433-7

  • Online ISBN: 978-1-4471-2434-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation